Nova Eye Medical (AU:EYE) has released an update.
Nova Eye Medical Limited has disclosed its adherence to the Corporate Governance Council recommendations for the financial year ended 30 June 2024, with its updated corporate governance statement available on their website. The statement, approved by the board and current as of 27 June 2024, highlights the company’s compliance with key governance principles, including board responsibilities, director appointments, and the role of the company secretary.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
